Ticker League

Shares Outstanding for Vertex Pharmaceuticals (VRTX)

As of · Reported

Metric

Latest period

256.30M

YoY change

+0.0%

5Y CAGR

-0.4%

Peak year (2020)

263.40M

Shares Outstanding history chart for Vertex Pharmaceuticals (VRTX) from 1990 to 2025

Latest: 258.00M

Shares Outstanding growth chart for Vertex Pharmaceuticals (VRTX) from 1990 to 2025

Latest: +0.0%

Shares Outstanding history table for Vertex Pharmaceuticals (VRTX) from 1990 to 2025

  • 2025258.00M+0.0%
  • 2024257.90M-1.0%
  • 2023260.50M+0.5%
  • 2022259.10M-0.3%
  • 2021259.90M-1.3%
  • 2020263.40M+1.0%
  • 2019260.67M+0.6%
  • 2018259.19M+2.4%
  • 2017253.22M+3.5%
  • 2016244.69M+1.4%
  • 2015241.31M+2.6%
  • 2014235.31M+4.6%
  • 2013224.91M+6.1%
  • 2012211.95M+1.5%
  • 2011208.81M+4.2%
  • 2010200.40M+15.7%
  • 2009173.26M+23.3%
  • 2008140.56M+9.0%
  • 2007128.99M+13.9%
  • 2006113.22M+26.9%
  • 200589.24M+13.6%
  • 200478.57M+2.0%
  • 200377.00M+1.7%
  • 200275.75M+1.7%
  • 200174.46M+10.0%
  • 200067.68M+32.6%
  • 199951.04M+0.9%
  • 199850.60M+4.3%
  • 199748.53M+29.8%
  • 199637.38M+9.5%
  • 199534.13M+8.6%
  • 199431.43M+25.7%
  • 199325.00M+2.9%
  • 199224.29M+66.2%
  • 199114.62M-25.7%
  • 199019.68M—

Shares Outstanding values are taken from Vertex Pharmaceuticals's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Shares Outstanding at Vertex Pharmaceuticals (VRTX)

According to Vertex Pharmaceuticals's latest reported financial statements, the company's latest reported diluted shares outstanding is 256.30M. Diluted weighted-average shares outstanding is the share count used to compute per-share metrics like EPS. Buybacks lower it; new issuance, stock-based compensation, and convertible securities raise it. Multiply by the stock price for market capitalization.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

The 2025 reading of Vertex Pharmaceuticals (VRTX) diluted shares outstanding is 258.00M – edged up 0.0% year-over-year.

Across 2020–2025 (5 years), Vertex Pharmaceuticals diluted shares outstanding produced a CAGR of -0.4% – with a net decline across the window.

Between 2020 and 2025, Vertex Pharmaceuticals diluted shares outstanding edged down 2.0%, falling from 263.40M to 258.00M.

The highest annual diluted shares outstanding of 263.40M was reported in 2020. The lowest in the available history was 14.62M in 1991.

Vertex Pharmaceuticals Shares Outstanding by Year

Vertex Pharmaceuticals Shares Outstanding 2025: 258.00M

Vertex Pharmaceuticals posted diluted shares outstanding of 258.00M in 2025, edged up 0.0% from 2024.

Vertex Pharmaceuticals Shares Outstanding 2024: 257.90M

In 2024, Vertex Pharmaceuticals reported diluted shares outstanding of 257.90M, edged down 1.0% below 2023.

Vertex Pharmaceuticals Shares Outstanding 2023: 260.50M

Vertex Pharmaceuticals diluted shares outstanding in 2023 was 260.50M, edged up 0.5% from 2022.

Vertex Pharmaceuticals Shares Outstanding 2022: 259.10M

2022's diluted shares outstanding for Vertex Pharmaceuticals came in at 259.10M, edged down 0.3% below 2021.

Vertex Pharmaceuticals Shares Outstanding 2021: 259.90M

Vertex Pharmaceuticals diluted shares outstanding in 2021 was 259.90M.

See more financial history for Vertex Pharmaceuticals (VRTX).

Sector peers by Shares Outstanding

Healthcare peers of Vertex Pharmaceuticals (VRTX), ranked by their latest diluted shares outstanding

Frequently asked questions

Vertex Pharmaceuticals (VRTX) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation